From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
- Author(s)
- Christian Hartinger, Stefanie Zorbas-Seifried, Michael Jakupec, Haralabos Zorbas, Bernhard Keppler
- Organisation(s)
- Department of Inorganic Chemistry
- External organisation(s)
- Max-Planck-Institut für Chemie (Otto-Hahn-Institut), Ludwig-Maximilians-Universität München
- Journal
- Journal of Inorganic Biochemistry
- Volume
- 100
- Pages
- 894-904
- No. of pages
- 11
- ISSN
- 0162-0134
- Publication date
- 2006
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 104003 Inorganic chemistry
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/1dd7be03-9df5-4ca8-96d2-3c5e08d06b05